Judge orders broader access to Plan B; Orexo lead drug fails IIa study for rhinitis;

> The FDA was wearing Republican-colored glasses when it barred teenage girls from the morning-after contraceptive Plan B, a federal judge ruled yesterday. U.S. District Judge Edward Korman lambasted the agency for putting politics above public health and ordered FDA to let 17-year-olds have access to the drug, known as Plan B. FiercePharma

> Sweden's Orexo says that a mid-stage trial of an experimental therapy for allergic rhinitis failed to demonstrate efficacy in reducing symptoms when compared to a placebo. But the developer still believes that the drug could work against COPD. FierceBiotech

> In a recent letter to Congress, a group of health policy experts urged the creation of a network to share information on Medicare and Medicaid patients to improve treatment received. In particular, Lynn Etheredge wants information to be shared on "dual eligibles"--low income, elderly patients who receive money for care from both Medicare and Medicaid. FierceHealthIT

> Hospital Impact's Tony Chen invites everyone to follow his blog on Twitter. Hospital Impact

And Finally... I can tell you right now, this is not the way to reconcile with anyone...at least I don't think it is. Article